1/25/2021 [LOI]
2/24/2021 |
CDC RFAs for special interest projects through HPDP |
CDC |
| 2/16/2021* |
Clinical Trial Planning: Therapeutic/Indication Pairing Strategies (U34) (Clinical Trial Not Allowed) |
National Center for Advancing Translational Sciences/NIH/DHHS |
| Rolling through: 5/1/2021 |
(NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) |
NIA/NIMH |
| Rolling submission: 3/25/2020 to 7/2/2021 |
NOSI regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) |
NIAID |
| Rolling submission: 3/25/2020 to 2/5/2021 |
NOSI regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 |
NIGMS |
| 2/16/2021* |
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
|
NIH/DHHS |
| 2/5/2021 |
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
|
NIH/DHHS |
| 2/3/2023 |
BARDA’s Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency Announcement |
DHHS |
| 2/16/2021* |
NIBIB Exploratory/Developmental Research Grant Program (R21 Clinical Trial Optional) |
NIBIB/NIH/DHHS |
| Rolling through: 5/3/2021* |
(NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) |
NIEHS/NIH/DHHS |
| 2/16/2021* |
NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional) |
NIBIB/NIH/DHHS |
| 21/5/2021 |
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) |
NIH/DHHS |
| 2/16/2021* |
NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) |
NIH/DHSS |
| Rolling through: 4/15/2021 |
Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement – Clinical Trial Optional) |
NIH/DHHS |
| Rolling through: 4/15/2021 |
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
|
NIH/DHHS |
| 2/5/2021 |
Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) |
NIH/DHHS |
| 2/3/2023 |
BARDA’s Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency Announcement |
DHHS |
| 2/5/2021 |
Clinic Testing Therapeutic/Indication Pairing Strategies (U01 Clinical Trial Required) |
NCATS/NIH/DHHS |
| None |
Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional) |
NIH/DHHS |
| Rolling through: 5/1/2021 |
Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities |
NIMHD |
| Rolling through: 1/25/2022 |
Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus |
NCATS |
| Rolling through: 4/16/2021 |
Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA |
NIAAA |
| Rolling through: 3/31/2021 |
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences |
NIH |
| 9/1/2022 |
National Dental Practice-Based Research Network Infrastructure Access (X01 Clinical Trial Not Allowed) |
NIDCR/NIH/DHHS |
| None posted |
Grants Program |
COVID-19 Early Treatment Fund (CETF) |
| None posted |
COVID-19 Rapid Response Fund |
Jacob and Valeria Langeloth Foundation |
| Varied |
NOSI: Promoting Fundamental and Applied Research in Inflammation Resolution |
NIEHS/NHLBI/NIAMS |
| Rolling |
Decentralized Clinical Studies RFP |
Gateway for Cancer Research |
| None |
Guide Notice of Information Highlighting Harmonization and Data Sharing Expectations for Supplement and Revision Projects Addressing Social, Behavioral, Economic and Health Impacts of the COVID-19 Public Health Emergency |
National Institute on Deafness & Other Communication Disorders/NIH/DHHS |
| Rolling |
RWJF Evidence for Action: Investigator-Initiated Research to Build a Culture of Health |
Robert Wood Johnson Foundation |
| Rolling |
Alkermes Education Grants |
Alkermes |
| Rolling |
Golden LEAF Open Grants Program |
Golden LEAF |
| 2/8/2021 |
|
NIH/NIDA/NCI |
| 2/1/2021 |
NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics In At-risk Older Adult Populations (R01 Clinical Trial Required) |
NIA/NIH/DHHS |
| 3/12/2021* |
Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project |
NIH/DHHS |
| None Posted |
Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional) |
NIH/DHHS |
| None Posted |
Covid-19 Research Credits Program |
Google |
| 3/2/2021 |
Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 – Clinical Trial Optional) |
NIH/DHHS |
| 2/3/2023 |
Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency Announcement |
BARDA/DHHS |
| 3/10/2021 |
Flash Grants |
North Carolina Biotechnology Center |
| Rolling starting 8/31/2020 |
Just Tech Covid-19 Rapid-Response Grants |
Social Science Research Council |
Rolling starting:
7/13/2020 |
Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) |
NIAID/NIH/DHHS |
| Rolling |
Small Grants Program in Behavioral Economics |
Sage (Russell) Foundation |
| none |
Dear Colleague Letter: Sentinel Cells for Surveillance and Response to Emergent Infectious Diseases (Sentinels) |
NSF |
| Rolling start: 8/6/2020 |
Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required) |
NIH/DHHS |
| 5/28/2021 |
COVID-19 Private Sector Engagement & Partnership Fund |
DOS |
| 10/5/2020-5/8/2021 |
Notice of Special Interest (NOSI): Comprehensive Care for Adults with Type 2 Diabetes Mellitus from Health Disparity Populations |
NIMH/NIH/DHHS |
| 1/14/2021 |
Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2 |
NIAID/NIH/DHHS |
| 10/5/2020-5/8/2023 |
Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities |
NIH/DHHS |
| 6/30/2021 |
2020 TIP Office Annual Program Statement to Address the Impacts of COVID-19 |
DOS |
| 2/8/2021 |
Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional) |
NIDA/NIH/DHHS |
| 2/16/2021 |
NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional) |
NIBIB/NIH/DHHS |
| 2/5/2021 |
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) |
NIH/DHHS |
| None |
NIBIB Research Project Grant (R01 Clinical Trial Required) |
NIH/DHHS |
| 1/5/2021 |
NIBIB Exploratory Clinical Trials for Small Business (R44 Clinical Trial Required) |
NIBIB/NIH/DHHS |
9/21/2020 [LOI/Pre-App]
11/25/2020 |
Foundation for Women’s Cancer Diversity and Inclusion Health Equity Research Grant |
Foundation for Women’s Cancer |
| 10/5/2020-7/16/2023 |
Emerging Viral Infections and their Impact on the Male and Female Reproductive Tract |
NICHD/NIH/DHHS |
| 2/3/2021 |
Mechanism for Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed) |
NIEHS |
| 11/26/2021 |
The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional) |
ORWH/NIH/DHHS |
11/1/2021 [LOI]
12/7/2021 |
Cooperative Research Agreements Related to the World Trade Center Health Program (U01) |
NIOSH/CDC/DHHS |
10/5/2020 –
5/8/2023 |
Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities |
NIH/DHHS |
10/26/2021 [Optional] [LOI/Pre-App]
11/26/2021 |
The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional) |
ORWH/NIH/DHHS |
| 2/5/2021 |
Notice of Special Interest (NOSI) – Research on Rehabilitation Needs Associated with the COVID-19 Pandemic |
NIH.DHHS |
| 3/17/2021 |
Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional) |
NIH/DHHS |
| 2/3/2021 |
BARDA’s Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency Announcement |
BARDA/DHHS |
| 3/31/2021 |
Dear Colleague Letter: Future of International Research Collaboration Post COVID-19 |
NSF |
11/1/2021 [LOI/Pre-app]
12/7/2021 |
Cooperative Research Agreements Related to the World Trade Center Health Program (U01) |
NIOSH/CDC/DHHS |
| 3/9/2021 |
National Dental Practice-Based Research Network Clinical Trial or Observational Study Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Optional) |
NIDCR |
Rolling through:
1/25/2022 |
Notice of Special Interest (NOSI): Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus |
NCATS/NIH/DHHS |
| 3/1/2021 |
Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) |
NIEHS/NIH/DHHS |
Rolling through:
4/14/2021 |
Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System |
NIH/DHHS |
Rolling through:
4/15/2021 |
Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus |
NIH/DHHS |
Rolling through:
4/15/2021 |
Notice of Special Interest (NOSI): Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA |
NIH/DHHS |
Rolling through:
5/1/2021 |
Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities |
NIH/DHHS |
Rolling through:
3/31/2021 |
Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences |
NIH/DHHS |
| Varied |
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) |
NIH/DHHS |
Rolling through:
4/15/2020 |
Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus |
NIH/DHHS |
Rolling through:
5/1/2020 |
Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) |
NIH/DHHS |
| None |
(NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) |
NCATS |
| 3/6/2021 |
Clinic Testing Therapeutic/Indication Pairing Strategies (U01 Clinical Trial Required) |
NCATS/NIH |
| 1/7/2021 – 9/8/2024 |
NOSI: Effects of smoking and vaping on the risk and outcome of COVID-19 infection |
NIDA/NIH/DHHS |
| 5/1/2021 |
NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) |
NIMH/NIAAA |
1/18/2021 [LOI/Pre-App]
2/18/2021 |
Conducting Research to Inform Pandemic Response and Recovery of Emergency-Affected Populations by Determining Public Health Needs, Improving Methods, and Integrating Services to Mitigate Morbidity and Mortality |
CGH/CDC/DHHS |
| 6/11/2021 |
Notice of Special Interest (NOSI): Emergency Awards: Notice of Special Interest (NOSI) on Pan-Coronavirus Vaccine Development Program Projects |
NIAID/NIH/DHHS |
| 2/8/2021 |
Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional) |
NIDA/NIH/DHHS |
| 2/22/2021 |
Strengthening Public Health Research and Implementation Science (Operations Research) to Control and Eliminate Infectious Diseases Globally |
DHHS/CDC |
| 2/8/2021 |
US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children |
DHHS/CDC |
| 8/9/2021 |
Defense Partnership Virtual Grant Program |
DOS |
| 2/1/2021 |
RESEARCH GRANT PROGRAMMES |
Olympic Studies Centre |
Rolling through:
6/1/2023 |
Notice of Special Interest: Administrative Supplements for COVID-19 Impacted NIMH Research |
NIMH/NIH/DHHS |
| 3/5/2021 |
Notice of Special Interest: Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional) |
NIH/DHHS |
| 6/1/2021 |
Notice of Special Interest (NOSI): Availability of Emergency Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs |
NCATS/NIH/DHHS |
| 2/5/2021 |
Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities |
NIH/DHHS |
| 3/2/2021 |
Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 – Clinical Trial Optional) |
NIH/DHHS |
2/2/2021 [LOI]
5/4/2021 |
Broad PCORI Funding Announcements — Cycle 1 2021 |
PCORI |
| 3/23/2021 |
Future of Work at the Human-Technology Frontier: Core Research (FW-HTF) |
NSF |
| 2/5/2021 |
Notice of Special Interest: Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases |
NIAMSD/NIH/DHHS |
